Chlorpheniramine; Phenylephrine

Drug Usage Statistics, United States, 2013 - 2022

Chlorpheniramine; Phenylephrine Summary for 2022

Top drug rank #329 ( 41)
Estimated number of prescriptions in the United States (2022) 107,375
Estimated number of patients in the United States (2022) 101,647
 
Average total drug cost (USD)  
Per prescription $24.03
Per day of therapy $0.92/day
Average out-of-pocket cost (USD)  
Per prescription $23.50
Per day of therapy $0.87/day

Total Prescriptions and Patients Per Year (2013 - 2022)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2013 473 -
2014 423  50
2015 451  28
2016 427  24
2017 428  1
Year Rank Change
2018 434  6
2019 441  7
2020 436  5
2021 370  66
2022 329  41

Drug Cost Over Time (2013 - 2022)

  • Cost Per Prescription Fill: Average cost per filled prescription regardless of how many days of therapy the prescription is filled for (e.g. 10 days, 30 days, 90 days, etc.)
  • Cost per Day of Therapy: The average cost per prescription fill divided by the days of therapy. For example, a 10-day antibiotic course costing $30 would be $3 per day. Similarly, a 30-day supply of an oral antihypetensive costing $30 would be $1 per day.

  • Total cost: The average total cost of the medication including the out-of-pocket cost (see below) plus the amount paid by other parties (Medicare, Medicaid, private insurance, Veterans Administration, TRICARE, other state/federal sources, Worker's compensation, and other miscellaneous sources)
  • Out-of-pocket cost: The average payment made by the patient which may include deductibles, coinsurance, copayments, or the cash price paid without insurance coverage.

Cost Per Prescription Fill (USD)

Cost Per Day of Therapy (USD/day)

Distribution of Dispensed Dosage Forms (2022)

No data available

Distribution of Days Supplied (2022)

"Days supply" is defined as the number of days that a prescription should last. For example, a prescription of 60 tablets that is taken twice daily has a day supply of 30 days.

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Acti PE
  • Allerfed
  • Allergy And Sinus PE
  • Aphedrid Cold And Allergy
  • Broncochem
  • Chlorpheniramine Maleate, Phenylephrine Hydrochloride
  • Cold Allergy
  • Cold And Allergy
  • Cold And Allergy PE
  • Dometuss-DA
  • ED A-hist
  • Nohist LQ
  • Sinus And Allergy
  • Sinus And Allergy PE
  • Sinus And Allergy Relief
  • Sinus And Allergy Relief PE
  • Sinus PE And Allergy
  • Sinus PE Plus Allergy
  • Sinus Plus Allergy PE
  • Stonarhini
  • Suphedrine PE
  • Suphedrine PE Sinus Plus Allergy
  • Wal-phed PE
  • Giltuss D Allergy And Congestion
  • Phenagil
Generic Drug Synonyms and Salts
  • Chlorpheniramine Maleate; Phenylephrine Hydrochloride
  • Phenylephrine Hydrochloride; Chlorpheniramine Maleate
  • Chlorpheniramine; Phenylephrine

FDA Approval Information

Established Pharmacologic Class (EPC): Histamine-1 Receptor Antagonist, alpha-1 Adrenergic Agonist
Initial FDA approval date: 11/16/2001
First FDA applicant: Sato Pharmaceutical Co., Ltd.
First dosage form: Tablet (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2013-2022. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 2024.08. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).

Search

Related Links

Mailing List

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

RxHero - Gamified learning for the Top 250 Drugs
 
©2024 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Sep 12, 2021
Back to Top
Top